Literature DB >> 3101502

Topical application of hyaluronic acid and chondroitin sulfate in the treatment of dry eyes.

M B Limberg, C McCaa, G E Kissling, H E Kaufman.   

Abstract

Twenty patients with keratoconjunctivitis sicca used three different viscoelastic tear formulations and a polyvinyl alcohol artificial tear for two weeks each. Each formulation was used once every two waking hours in a controlled double-masked study. Eighteen patients reported marked improvement over the course of the study, in terms of the severity of itching, burning, and foreign body sensation. Corneal staining and mucous strand formation were also reduced in patients with these manifestations. No formulation was preferred by a majority of patients or proved superior in treating signs of keratoconjunctivitis sicca. However, patients with low Schirmer test scores uniformly preferred a solution containing chondroitin sulfate, while patients with moderate Schirmer test scores tended to prefer a solution of polyvinyl alcohol or hyaluronic acid.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3101502     DOI: 10.1016/s0002-9394(14)74226-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.

Authors:  Françoise Brignole; Pierre-Jean Pisella; Bénédicte Dupas; Vincent Baeyens; Christophe Baudouin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

2.  Histopathological changes on the ocular surface of New Zealand white rabbits after instillation of a fixed combination of 0.09 % xanthan gum and 0.1 % chondroitin sulfate.

Authors:  Angélica Y Contreras-Rubio; Leopoldo Baiza-Durán; Oscar Olvera-Montaño; Mónica Miranda-Robles; José Bonilla-García; Arieh Mercado-Sesma
Journal:  Int Ophthalmol       Date:  2016-02-27       Impact factor: 2.031

3.  Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye.

Authors:  N Yokoi; A Komuro; K Nishida; S Kinoshita
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

4.  Sodium hyaluronate eyedrops in the treatment of dry eyes.

Authors:  S Shimmura; M Ono; K Shinozaki; I Toda; E Takamura; Y Mashima; K Tsubota
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

Review 5.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

6.  Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion.

Authors:  Cynthia Matossian; William Trattler; Jennifer Loh
Journal:  Clin Ophthalmol       Date:  2021-05-11

7.  Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial.

Authors:  Ana L Pérez-Balbuena; Juan C Ochoa-Tabares; Sandra Belalcazar-Rey; Cristian Urzúa-Salinas; Laura R Saucedo-Rodríguez; Regina Velasco-Ramos; Raúl G Suárez-Sánchez; Adolfo D Rodríguez-Carrizalez; Aldo A Oregón-Miranda
Journal:  BMC Ophthalmol       Date:  2016-09-20       Impact factor: 2.209

Review 8.  Over the counter (OTC) artificial tear drops for dry eye syndrome.

Authors:  Andrew D Pucker; Sueko M Ng; Jason J Nichols
Journal:  Cochrane Database Syst Rev       Date:  2016-02-23

9.  Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye.

Authors:  Jun Woong Moon; Hyun Joo Lee; Ki Chul Shin; Won Ryang Wee; Jin Hak Lee; Mee Kum Kim
Journal:  Korean J Ophthalmol       Date:  2007-12

10.  Effects of chondrocyte-derived extracellular matrix in a dry eye mouse model.

Authors:  Chae Eun Kim; Ha Na Oh; Ji Hyun Lee; Jae Wook Yang
Journal:  Mol Vis       Date:  2015-10-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.